Loading viewer...
investor_presentation
Format: PDF investor_presentation
VYNE Therapeutics is a biopharmaceutical company developing proprietary therapies for immuno-inflammatory conditions and rare skin diseases. The company's pipeline focuses on JAK/sphingosine-1 receptor modulator combinations and BET inhibitors, with near-term clinical catalysts expected for lead programs FMX114, VYN201, and VYN202.
presentation
investor_presentation
46 Pages
Eckert & Ziegler
investor_presentation
Akbank